254. Porphyria Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 79 / Drugs : 44 - (DrugBank : 17) / Drug target genes : 19 - Drug target pathways : 35
| Other names | - | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
47 patients Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 254-01, 254-02, 254-03, 254-04, 254-05, 254-06, 254-07, 254-08 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 14-12-17. Porphyria | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 254-1. | Acute intermittent porphyria;AIP; | 14-12-17. Porphyria | |
| 254-2. | Hereditary coproporphyria;HCP; | 14-12-17. Porphyria | |
| 254-3. | Variegate porphyria;VP; | 14-12-17. Porphyria | |
| 254-4. | Erythropoietic protoporphyria;EPP; | 14-12-17. Porphyria | |
| 254-5. | Porphyria cutanea tarda;PCT; | 14-12-17. Porphyria | |
| 254-6. | Congenital erythropoietic porphyria;CEP; | 14-12-17. Porphyria | |
| 254-7. | X-linked dominant protoporphyria;XLDP; | 14-12-17. Porphyria | |
| 254-8. | Hepatoerythropoietic porphyria;HEP; | 14-12-17. Porphyria | |